CI

At a glance

ClinicalIndex Comparison Record
Phase 3Recruiting· 390 target
Drug / intervention
Sublobar Resectionprocedure
Likely dose
Not stated in record
Key inclusion· 8
  • ✓Aged 18-80 years
  • ✓ECOG performance status 0 or 1
  • ✓No prior lung cancer surgery
  • ✓Resectable peripheral cT1N0M0 tumors
Key exclusion· 5
  • ✕Not cT1N0M0 stage
  • ✕Cannot be completely resected by sublobar resection
  • ✕Invasive lung adenocarcinoma or non-lung adenocarcinoma histology
  • ✕Prior lung cancer surgery

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06031181
NCT06031181Phase 3RecruitingMonitorUpdated 30mo ago · Completion was 5mo ago
Slow Enrollment
Long Recruiting
Monitor
CompareCT.gov

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section: a Single-arm, Multi-center, Phase III Trial

Fudan University·interventional·Posted Sep 11, 2023·Updated Dec 13, 2023

In Brief

A Phase 3 clinical trial evaluating Sublobar Resection for Lung Adenocarcinoma and 2 related conditions. Currently recruiting, targeting 390 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Adenocarcinoma, Frozen Section, Sublobar Resection
CountriesChina
Collaborators--

Timeline

Phase 3Recruiting
20242025202620272028202920302031
First PostedSep 11, 2023
Enrollment StartMar 31, 2023
Primary CompletionJan 1, 2026
Study CompletionDec 31, 2030
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 2.8 years ago

Interventions

Sublobar Resectionprocedure

Sublobar Resection includes segmentectomy and wedge resection